Itamar Medical

Israel
Caesarea, Haifa, Israel

Company profile

Itamar Medical company profile

Itamar Medical is a publicly traded medical device company based in Israel’s Caesarea Industrial Park that develops non-invasive medical devices using the proprietary PAT (Peripheral Arterial Tone) signal. Since its founding in 1997, the Company has engaged in research and development of non-invasive medical devices for diagnosis of various medical conditions, including cardiovascular disease and respiratory disorders. The first two product lines from Itamar Medical, based on unique technology developed by the Company, are the WatchPAT™ home appliance for respiratory sleep disorder diagnosis, and EndoPAT™, the only device approved by the FDA for testing endothelial (arterial) function and assessing the risk of coronary artery disease and other cardiovascular diseases.

Business identity

Contact email
[email protected]
Phone number
+97246177003
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$1M-$10M
Founded
1997-01-01, Year

Headquarters

Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
12
Total equity funding
$91.4M
Last funding
Post IPO Secondary / $70M / 2021-02-07
Last equity funding
Post IPO Equity / $8M
Investors
8
Lead investors
2
Founders
2
Articles
36
Exited on
2012-06-22

Founders and investors

Founders

Giora YaronPeretz Lavie

Lead investors

EISMEAViola Growth

Investors

Bay City CapitalDeerfield Capital ManagementEISMEAGolden Gate CapitalViola Growth